Table 2.

Clinical parameters for data analysis 2.

Clinical parameter	1st pregnancy w/ GDM (N = 150)		2nd pregnancy w/ GDM (N = 20)		2nd pregnancy w/o GDM (N = 22)
Race/ethnicity	White (4 Hispanic of 113 White)	113	White (1 Hispanic of 18 White)	18	White (0 Hispanic of 20 White)	20
	American Indian	1	American Indian	0	American Indian	0
	Alaska Native, Native Hawaiian, or other Pacific Islander	1	Alaska Native, Native Hawaiian, or other Pacific Islander	0	Alaska Native, Native Hawaiian, or other Pacific Islander	0
	Asian	20	Asian	1	Asian	0
	Black or African Am.	10	Black or African Am.	0	Black or African Am.	2
	Multiracial	2	Multiracial	0	Multiracial	0
	Undocumented	3	Undocumented	1	Undocumented	0
Smoking	Never smoked	111	Never smoked	17	Never smoked	18
	Quit > 1 yr	5	Quit > 1 yr	2	Quit > 1 yr	1
	Quit during this pregnancy 12	12	Quit during this pregnancy 0	0	Quit during this pregnancy	0
	Currently smoking	14	Currently smoking	1	Currently smoking	2
	Not documented	8	Not documented	0	Not documented	1
DM in family	DM in family (36 out of 150)		DM in family (0 out of 20)		DM in family (6 out of 22)
GDM clinical management	Diet and lifestyle	97∗	Diet and lifestyle	10	Normal treatment procedures for pregnancy
	Glyburide	45	Glyburide	6
	Insulin	8	Insulin	3
	Other	0	Other	1

^∗105 women began as diet and lifestyle treatment, but 8 were changed to glyburide treatment later in their pregnancy.